close
Solutions
keyboard_arrow_downServices
keyboard_arrow_downSupport & Resources
keyboard_arrow_downCompany
keyboard_arrow_downContact
Randox Health search
The RIQAS Coagulation EQA programme is designed to monitor the performance of 17 routine coagulation tests and specialised factor assays. Two flexible yet cost effective programme options are available.
Lyophilised material for enhanced stability
Submit results and view reports online via RIQAS.Net
World's largest EQA scheme ensures peer groups are maximised
Monthly reporting for earlier identification of test system errors
Cycle Starts - January 2026
Accredited to ISO/IEC 17043:2023
Get in touch to discover more
To find out more about RIQAS EQA or to get in touch with your local Randox Representative, enquire now.
| Description | Frequency | Size | Cat No | |
|---|---|---|---|---|
| 5 Routine Parameters Only + 1 pilot | Monthly | 12 x 1 ml | RQ9135/a | |
| Full 17 Parameters + 1 pilot | Monthly | 12 x 1 ml | RQ9135/b |
Routine Parameters
- aPTT
- Fibrinogen
- PT (including INR)
- Antithrombin III
- TT
Parameters
- aPTT
- Factor II
- Factor XI
- PT (including INR)
- Factor V
- Factor XII
- TT
- Factor VII
- Plasminogen
- Fibrinogen
- Factor VIII
- Protein C
- Antithrombin III
- Factor IX
- Protein S
- D-dimer*
- Factor X
- Protein S (Free)
* – Pilot study ongoing
Please note, product availability may vary country to country.
Related RIQAS EQA Programmes
Haematology
Specific Proteins
Therapeutic Drugs
